Total Payments
$116,353
2024 Payments
$42,537
Companies
34
Transactions
275
Medicare Patients
4,817
Medicare Billing
$590,830
Payment Breakdown by Category
Other$99,750 (85.7%)
Food & Beverage$8,449 (7.3%)
Travel$5,657 (4.9%)
Consulting$1,515 (1.3%)
Research$956.69 (0.8%)
Education$25.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $99,750 | 43 | 85.7% |
| Food and Beverage | $8,449 | 221 | 7.3% |
| Travel and Lodging | $5,657 | 7 | 4.9% |
| Consulting Fee | $1,515 | 1 | 1.3% |
| Unspecified | $956.69 | 1 | 0.8% |
| Education | $25.70 | 2 | 0.0% |
Payments by Type
General
$115,397
274 transactions
Research
$956.69
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $89,486 | 95 | $0 (2024) |
| Amgen Inc. | $20,319 | 27 | $0 (2024) |
| GENZYME CORPORATION | $2,069 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $968.74 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $838.45 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $682.07 | 30 | $0 (2024) |
| United Therapeutics Corporation | $367.35 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $258.88 | 11 | $0 (2024) |
| PFIZER INC. | $193.49 | 9 | $0 (2024) |
| Pulmonx Corporation | $164.85 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42,537 | 121 | AstraZeneca Pharmaceuticals LP ($38,953) |
| 2023 | $44,688 | 68 | AstraZeneca Pharmaceuticals LP ($30,626) |
| 2022 | $27,643 | 33 | AstraZeneca Pharmaceuticals LP ($19,783) |
| 2021 | $629.71 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($297.79) |
| 2020 | $101.24 | 6 | GlaxoSmithKline, LLC. ($26.01) |
| 2019 | $177.91 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($126.91) |
| 2018 | $157.65 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($102.87) |
| 2017 | $419.01 | 20 | PFIZER INC. ($169.84) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Immunology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.80 | General |
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: Immunology | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $1,124.20 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Pulmonx Corporation | ZEPHYR DELIVERY CATHETER (Device), ZEPHYR ENDOBRONCHIAL VALVE, PULMONX CHARTIS TABLET CONSOLE | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: PULMONOLOGY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $117.49 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis | E.R. Squibb & Sons, L.L.C. | $956.69 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,496 | 2,614 | $492,157 | $167,910 |
| 2022 | 23 | 1,483 | 2,472 | $505,404 | $178,092 |
| 2021 | 24 | 1,400 | 2,410 | $537,460 | $188,730 |
| 2020 | 13 | 438 | 560 | $142,820 | $56,097 |
Total Patients
4,817
Total Services
8,056
Medicare Billing
$590,830
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 117 | 256 | $107,520 | $41,191 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 304 | $63,840 | $28,007 | 43.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 118 | 169 | $48,165 | $22,113 | 45.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 94 | 223 | $48,168 | $20,170 | 41.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $21,900 | $9,819 | 44.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 182 | 221 | $33,150 | $8,110 | 24.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 178 | 210 | $24,150 | $7,651 | 31.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 168 | 194 | $28,518 | $5,189 | 18.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $14,700 | $4,573 | 31.1% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 21 | 22 | $12,100 | $3,546 | 29.3% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 28 | 30 | $22,500 | $3,413 | 15.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 47 | 52 | $20,800 | $3,214 | 15.5% |
| 86003 | Measurement of antibody (ige) to allergic substance, crude allergen extract, each | Office | 2023 | 17 | 595 | $8,925 | $3,044 | 34.1% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 20 | 21 | $8,064 | $2,235 | 27.7% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 16 | 16 | $3,840 | $1,150 | 29.9% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 15 | 16 | $10,400 | $1,014 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $2,700 | $979.20 | 36.3% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 53 | 63 | $2,583 | $756.88 | 29.3% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 11 | 11 | $5,775 | $528.70 | 9.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 26 | 29 | $2,175 | $496.97 | 22.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 43 | 52 | $1,300 | $436.80 | 33.6% |
| 82785 | Ige (immune system protein) level | Office | 2023 | 17 | 17 | $884.00 | $274.21 | 31.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 123 | 275 | $115,500 | $46,802 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 151 | 242 | $68,970 | $31,601 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 217 | $45,570 | $20,509 | 45.0% |
About Dr. Hector Sanchez, MD
Dr. Hector Sanchez, MD is a Pulmonary Disease healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1124446513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hector Sanchez, MD has received a total of $116,353 in payments from pharmaceutical and medical device companies, with $42,537 received in 2024. These payments were reported across 275 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($99,750).
As a Medicare-enrolled provider, Sanchez has provided services to 4,817 Medicare beneficiaries, totaling 8,056 services with total Medicare billing of $590,830. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine
- Location Wilmington, NC
- Active Since 04/02/2014
- Last Updated 12/02/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1124446513
Products in Payments
- TEZSPIRE (Biological) $106,930
- FASENRA (Biological) $2,358
- DUPIXENT (Biological) $729.56
- NUCALA (Biological) $521.22
- OFEV (Drug) $433.12
- ELIQUIS (Drug) $178.15
- CHARTIS CATHETER (Device) $161.95
- ZERBAXA (Drug) $120.06
- TRELEGY ELLIPTA (Drug) $117.61
- STIOLTO RESPIMAT (Drug) $115.45
- TYVASO (Drug) $88.63
- PURIFIED CORTROPHIN GEL (Drug) $76.82
- OPSUMIT (Drug) $74.42
- Prolastin-C Liquid (Biological) $70.78
- GLASSIA (Biological) $61.34
- YUPELRI (Drug) $50.44
- ILLUMISITE (Device) $41.65
- AirDuo Digihaler (Drug) $40.74
- AIRSUPRA (Drug) $36.81
- Arikayce (Drug) $32.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Wilmington
Dr. Mitchell Lee, Md, MD
Pulmonary Disease — Payments: $270,089
Pulmonary Disease $270,089
Dr. Kevin O'neil, Md, MD
Pulmonary Disease — Payments: $1,596
Pulmonary Disease $1,596
Clifton Hunt, Md, MD
Pulmonary Disease — Payments: $1,011
Pulmonary Disease $1,011
William Credle, Md, MD
Pulmonary Disease — Payments: $678.15
Pulmonary Disease $678.15
Dr. Brian Legere, Md, MD
Pulmonary Disease — Payments: $498.97
Pulmonary Disease $498.97
Dr. Christian Lloyd, Md, MD
Pulmonary Disease — Payments: $279.25
Pulmonary Disease $279.25